These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7113022)

  • 21. [Status of hearing in patients with otosclerosis shortly after conservative therapy with sodium fluoride].
    Galochkin VI
    Vestn Otorinolaringol; 1986; (4):34-8. PubMed ID: 3750615
    [No Abstract]   [Full Text] [Related]  

  • 22. Current status of fluoride therapy for otosclerosis.
    Snow JB
    Am J Otol; 1985 Jan; 6(1):56-8. PubMed ID: 3976859
    [No Abstract]   [Full Text] [Related]  

  • 23. [Importance of histologic examination of footplate pieces to provide an indication for postoperative sodium fluoride. Study of 58 stapedectomies].
    Cura O; Gunhan O; Palandoken M; Olgun L; Oztop F
    Rev Laryngol Otol Rhinol (Bord); 1982; 103(3):203-6. PubMed ID: 7156539
    [No Abstract]   [Full Text] [Related]  

  • 24. Fluoride therapy for otosclerosis.
    Shambaugh GE
    Arch Otolaryngol Head Neck Surg; 1990 Oct; 116(10):1217. PubMed ID: 2206512
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical studies on fluoride in otospongiosis.
    Causse JR; Causse JB
    Am J Otol; 1985 Jan; 6(1):51-5. PubMed ID: 2579565
    [No Abstract]   [Full Text] [Related]  

  • 26. [Results of conservative treatment of otosclerosis by endoaural electrophoresis of fluorine preparations and ascorbic acid].
    Gukovich VA; Avramenko LV; Martyniuk LA
    Zh Ushn Nos Gorl Bolezn; 1977; (2):21-8. PubMed ID: 855459
    [No Abstract]   [Full Text] [Related]  

  • 27. Fluoride therapy for otosclerosis.
    Kerr GS; Hoffman GS
    Ear Nose Throat J; 1989 Jun; 68(6):426, 428-9. PubMed ID: 2663438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Objective changes in trypsin, alpha 1-antitrypsin, and alpha 2-macroglobulin values as a result of sodium fluoride treatment in patients with otosclerosis.
    Causse JR; Uriel J; Berges J; Bretlau P; Shambaugh GE; Causse JB
    Am J Otol; 1985 Jan; 6(1):38-42. PubMed ID: 2579564
    [No Abstract]   [Full Text] [Related]  

  • 29. Adult fluoride therapy for ostosclerosis (otospongiosis).
    Shambaugh GE
    Arch Otolaryngol; 1983 May; 109(5):353. PubMed ID: 6847492
    [No Abstract]   [Full Text] [Related]  

  • 30. [Biological bases for a fluoride treatment of otospongiosis. Experimental and clinical results].
    Causse J; Chevance LG
    Ann Otolaryngol Chir Cervicofac; 1973 Mar; 90(3):139-60. PubMed ID: 4717370
    [No Abstract]   [Full Text] [Related]  

  • 31. Stapedius reflex in the monitoring of NaF treatment of subclinical otosclerosis.
    Colletti V; Fiorino FG
    Acta Otolaryngol; 1987; 104(5-6):447-53. PubMed ID: 3434266
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Otospongiosis and sodium fluoride. A blind experimental and clinical evaluation of the effect of sodium fluoride treatment in patients with otospongiosis.
    Bretlau P; Causse J; Causse JB; Hansen HJ; Johnsen NJ; Salomon G
    Ann Otol Rhinol Laryngol; 1985; 94(2 Pt 1):103-7. PubMed ID: 3888030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Further experiences with moderate dosage sodium fluoride for sensorineural hearing loss, tinnitus and vertigo due to otospongiosis.
    Shambaugh GE
    Adv Otorhinolaryngol; 1977; 22():35-42. PubMed ID: 868707
    [No Abstract]   [Full Text] [Related]  

  • 34. Otosclerosis 1981 to 1985. Our four-year review and current perspective.
    Wiet RJ; Raslan W; Shambaugh GE
    Am J Otol; 1986 May; 7(3):221-8. PubMed ID: 3521305
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical experience and experimental findings with sodium fluoride in otosclerosis (otospongiosis).
    Causse J; Chevance LG; Shambaugh GE
    Ann Otol Rhinol Laryngol; 1974; 83(5):643-7. PubMed ID: 4412470
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of sodium fluoride on bone. Application to otosclerosis and other decalcifying bone diseases.
    Shambaugh GE; Petrovic A
    JAMA; 1968 Jun; 204(11):969-73. PubMed ID: 5694686
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical studies of F-Varnish, a dentin sensitivity repressor].
    Nishiwaki A; Umeno K
    Shikai Tenbo; 1979; 54(4):707-12. PubMed ID: 296972
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of sodium fluoride on otosclerotic activity as determined by strontium.
    Linthicum FH; House HP; Althaus SR
    Ann Otol Rhinol Laryngol; 1973; 82(4):609-15. PubMed ID: 4721187
    [No Abstract]   [Full Text] [Related]  

  • 39. Menière's syndrome: an approach to therapy.
    Brookler KH; Glenn MB
    Ear Nose Throat J; 1995 Aug; 74(8):534-8, 540, 542. PubMed ID: 7555871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Osteogenesis imperfecta and sodium fluoride therapy].
    Fengler F; Franke J; Schützmannsky G; Drückler E
    Beitr Orthop Traumatol; 1979 Dec; 26(12):664-70. PubMed ID: 543864
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.